AAMERICAN ASSETARCHIVE™← Return to the catalog

AAA-0181 · Archive record

VERTEX PHARMACEUTICALS GLOBAL HEADQUARTERS

50 Northern Ave, Boston, MA 02210

A digital archive object associated with VERTEX PHARMACEUTICALS GLOBAL HEADQUARTERS.

Source description / title

VERTEX PHARMACEUTICALS GLOBAL HEADQUARTERS

VERTEX PHARMACEUTICALS GLOBAL HEADQUARTERS — PropyKeys ERC-721 digital asset associated with 50 Northern Ave, Boston, MA 02210

Archive summary

An onchain digital twin associated with 50 Northern Ave, Boston, MA 02210.

Archive significance

Filed in Pharmaceutical, Biotechnology & Healthcare within the Medicine, Research & Institutional Knowledge collection, with the archive tags Healthcare / Life Sciences, Corporate / Commercial.

Original authored description

DIGITAL ASSET DESCRIPTION The RWA tied to 50 Northern Avenue, Boston, MA 02210 represents ownership exposure to the global headquarters of Vertex Pharmaceuticals, a company that became known for pursuing some of medicine's most difficult challenges at their biological root. Located within Boston's Seaport District, this campus serves as the command center of an institution whose work helped redefine what is possible in the treatment of genetic disease. What makes this asset significant is Vertex's willingness to focus on conditions that were once considered beyond the reach of modern medicine. Rather than treating symptoms alone, the company became known for developing therapies designed to address the underlying biological mechanisms of disease, helping establish a new standard for precision-driven treatment. The blockchain connection is direct. Both biotechnology and blockchain emerged from the belief that solving foundational problems can create transformational outcomes. One seeks to correct failures within biological systems, while the other seeks to establish trust within digital systems. As a blockchain-based real-world asset, 50 Northern Avenue represents verifiable exposure to one of the defining biotechnology institutions of the twenty-first century. The significance of this address is not the headquarters itself. The significance is its connection to a company that helped demonstrate that genetic diseases once viewed as lifelong certainties could become targets for scientific intervention and breakthrough treatment. ## Archived & Preserved by Jacob Alan Ervin Lovaas🇺🇸🎩 June 7, 2026

Catalog placement

Primary world
Medicine, Research & Institutional Knowledge
Primary group
Pharmaceutical, Biotechnology & Healthcare
Geography
Massachusetts
Archive revision
2026-08-20
Archive flags
Cataloged record

Layer 01 — Source Record

Token ID
308544
Network
Base
Standard
ERC-721
Contract
0xa239b9b3e00637f29f6c7c416ac95127290b950e
Canonical Record Fingerprint
Chain ID: 8453 (Base Mainnet)
Record Hash (SHA-256): a03e3f76506d1ea4c329551f772b35ddb39772dcbcd6d9b6e31f1838bc642980
View public blockchain reference

Layer 02 — Archive Reading · Source Trail

This record is drawn from the complete inventory and the curatorial catalog.

Source title
VERTEX PHARMACEUTICALS GLOBAL HEADQUARTERS
Source artifacts
AAA-INV-2026-v1.0 · Canonical Token & Address Inventory Ledger (566 Records) · Complete Inventory · AAA-CAT-2026-v1.0 · Primary Group Taxonomy & Curatorial Classification Registry (36 Groups) · Curatorial Catalog · AAA-DESC-2026-v1.0 · Systemic Significance & Portfolio Crosswalk Compendium · RWA Description
Onchain reference
Base · ERC-721 · Token 308544

This record is the mirrored digital twin onchain associated with 50 Northern Ave, Boston, MA 02210.

How this record is built